Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - HK
$ 6.13
0.822 %
$ 79.8 M
Market Cap
-19.16
P/E
INCOME STATEMENT
0
REVENUE
-4.74 M
OPERATING INCOME
-4.36 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Regencell Bioscience Holdings Limited
| Revenue | 0 |
| Cost Of Revenue | 746 K |
| Gross Profit | -746 K |
| Operating Expenses | 3.99 M |
| Operating Income | -4.74 M |
| Other Expenses | -374 K |
| Net Income | -4.36 M |
Income Statement
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Dec-2017 | Dec-2016 | Dec-2015 | Jan-2015 | Dec-2013 | Dec-2012 | Dec-2010 | Dec-2009 | Jan-2009 | Dec-2007 | Dec-2006 | Dec-2004 | Jan-2004 | Dec-2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 3 163.0 | 3 197.1 | 3 127.3 | 2 990.1 | 3 038.1 | 2 824.2 | 2 807.9 | 2 893.9 | 2 771.0 | 2 661.0 | 2 598.0 | 2 468.0 | 2 489.0 | 2 140.0 |
| GROSS PROFIT | ||||||||||||||||||||
| Cost Of Revenue | 0.7 | 0.8 | 0.6 | 26.5 K | 9.52 K | 0 | 123.0 | 1 226.8 | 1 207.5 | 111.0 | 111.0 | 101.0 | 101.0 | 1 157.1 | 106.0 | 103.0 | 104.0 | 94.0 | 92.0 | 84.0 |
| Gross Profit | (0.7) | (0.8) | (0.6) | 26.5 K | 9.52 K | 0 | 3 040.0 | 1 970.3 | 1 919.8 | 2 879.1 | 2 927.1 | 2 723.2 | 2 706.9 | 1 736.8 | 2 665.0 | 2 558.0 | 2 494.0 | 2 374.0 | 2 397.0 | 2 056.0 |
| OPERATING INCOME | ||||||||||||||||||||
| Operating Expenses | 4.0 | 6.3 | 7.6 | 1.4 | 0.8 | 0.4 | 1 310.1 | 1 626.1 | 1 580.8 | 1 193.9 | 1 158.8 | 1 054.1 | 1 233.0 | 1 423.4 | 2 487.0 | 2 339.0 | 2 289.0 | 2 146.0 | 2 110.0 | 1 856.0 |
| Selling, General and Administrative Expenses | 2.9 | 4.7 | 5.1 | 0.9 | 0.4 | 0.2 | 86.6 | 512.2 | 500.3 | 74.4 | 73.7 | 68.8 | 66.7 | 443.0 | 62.0 | 63.0 | 65.0 | 63.0 | 62.0 | 65.0 |
| Research and Development Expenses | 1.1 | 1.6 | 2.5 | 0.4 | 0.4 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (4.7) | (6.3) | (7.6) | (1.4) | (0.8) | (0.4) | 271.7 | 344.2 | 339.0 | 306.4 | 339.8 | 334.2 | 215.8 | 313.4 | 284.0 | 322.0 | 308.0 | 321.0 | 379.0 | 283.0 |
| PRE-TAX INCOME | ||||||||||||||||||||
| Interest Income Expense | 0 | 0 | 23.2 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 152.8 | (124.0) | (112.0) | (125.0) | (95.0) | (72.0) | 61.0 |
| Total Other Income | 0.4 | 0.2 | 23.2 K | 34.6 K | 0 | 0 | (57.8) | (62.5) | (85.7) | (127.8) | (75.2) | (98.3) | (140.1) | (156.2) | (161.0) | 283.0 | (164.0) | (179.0) | (73.0) | (75.0) |
| Pre-Tax Income | (4.4) | (6.1) | (7.6) | (1.3) | (0.8) | (0.4) | 213.9 | 281.7 | 253.3 | 178.6 | 264.6 | 235.9 | 75.7 | 157.2 | 123.0 | 605.0 | 144.0 | 142.0 | 306.0 | 208.0 |
| NET INCOME | ||||||||||||||||||||
| Tax Provision | 0.3 | (0.2) | (0.2) | (0.2) | 1 | 391 | 101.6 | 111.2 | 100.1 | 73.4 | 107.0 | 91.2 | 48.7 | 61.9 | 50.0 | 242.0 | 57.0 | 59.0 | 121.0 | 89.0 |
| Net Income | (4.3) | (5.9) | (7.4) | (1.3) | (0.8) | (0.4) | 112.3 | 170.4 | 153.4 | 105.6 | 157.7 | 144.8 | 77.6 | 95.5 | 72.0 | 363.0 | 86.0 | 82.0 | 185.0 | 117.0 |
| EPS | 0.33 | 0.45 | 0.57 | 0.11 | 0.0643 | 0.0309 | 0.72 | 1.09 | 0.98 | 0.68 | 1.02 | 0.94 | 0.51 | 0.62 | 62.1 | 63.1 | 65.9 | 0.57 | 1.34 | 0.83 |